Centrum Multi + Omega-3 (60 Count, 2 Month Supply) Adult Multivitamin And Omega-3 Supplement For Women Over 50, Multivitamin Support For Your Heart, Vitamins B6, B12 And Folate

Take better care of yourself with the help of Centrum Multi + Omega-3 Adult Multivitamin and Omega-3 Supplement for women age 50 and over. This new formula contains all the benefits of a Women’s Multivitamin, and adds Omega-3 fish oil for heart health(4) in one easy-to-swallow softgel capsule for a better multivitamin. There’s no need to add another pill to your daily routine. When you take Centrum Multi + Omega-3, you’re getting 200 mg of Omega-3 per serving. Supportive but not conclusive research shows that consumption of EPA and DHA Omega-3 fatty acids may reduce the risk of coronary heart disease. Supplement your health and nutrition needs with additional vitamins including B6, B12, A, C, D, E, Folate, Magnesium and Zinc. Trust Centrum, the #1 doctor and pharmacist recommended multivitamin brand (3), to provide advanced support for whole body benefits with Centrum Multi + Omega-3 for Women 50+. (1) Supportive but not conclusive research shows that consumption of EPA and DHA Omega-3 fatty acids may reduce the risk of coronary heart disease. (3) Based on IMS Health data (adult multivitamin brands in the US as of March 2017), and 2017 Pharmacy Times Survey of Pharmacists' OTC Recommendations. (4) Vitamins C and E to support healthy circulation and 3 B-Vitamins plus Magnesium for heart health. * These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Satisfaction Guarantee If for any reason you are not satisfied with any GSK Consumer Healthcare product, GSK Consumer Healthcare will provide you with a reimbursement within 45 days of the date of purchase. Please note that because GSK is unable to control the quality of our products sold by unauthorized sellers, the Guarantee is not available for products purchased from unauthorized sellers due to potential quality issues outside GSK’s control